Otc - Active Ingredient
Allantoin 1%
Psoriasis Cream
FDA Label NDC 73239-1905
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Kanamed Inc. for the product Psoriasis Cream (NDC 73239-1905). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, indications & usage, inactive ingredient, dosage & administration, warnings, otc - keep out of reach of children, otc - purpose, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Indications & Usage
Temporarily protects and helps relieve chapped or cracked skin
Inactive Ingredient
- Hemp seed oil
- Shea Butter
- Aloe vera Juice
- Avocado Oil
- Jojoba Extract
- Honey Extract
- Peppermint Extract
- Carrot Seed Oil
- Glycerine
- Stearic Acid
- EDTA
- Arcel 165
- Carbopol U-10,
- Cetyl Alcohol
- BHT
- Cetearyl Alcohol
- Cetearyl Glucoside
- Phenoxyethanol
- Ethylhexlglycerin
- Sorbitan Stearate
- Cyclopentasiloxane
- Phenyl Trimethicone
- Dimethiconol
- C12-15 Alkyl Benzoate
- Dimethicone Crosspolymer
- Caustic Soda/Sodium Hydroxide
- Capric Caprylic Triglyceride
- Polysorbate 60
- Ethylenediaminetetraacetic Acid
- Glycerine
- Carbopol U10
- Caustic Soda/Sodium hydroxide
- Propylene Glycol
- Sodium Benzonate
- DM Water
- Perfume
- Imidaolidnyl Urea
Dosage & Administration
Apply as needed
Warnings
- For external use only
- When using this product do not get into eyes
- Conditions worsens
- symptoms last more than 7 days or clear up and occur again within a few days
STOP use and ask a doctor if:
Otc - Keep Out Of Reach Of Children
Keep out of reach of children.
Otc - Purpose
Skin Protectant
* Please review the disclaimer below.
